Trending Topic

roflilumast foam
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The FDA recently approved roflumilast 0.3% foam for the treatment of plaque psoriasis of the scalp and body in both adolescents and adults. To better understand how this newly approved therapy fits into clinical practice, what the data show and which patients are likely to benefit, we spoke with Dr Jennifer Soung (Harbor University of California, Los Angeles and Southern California Dermatology, Santa Ana, CA, USA), a key investigator on the phase 3 ARRECTOR trial.

< 1 min

Honouring Prof. Marcus Maurer

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 20th 2024

We are deeply saddened to learn of the passing of Prof. Marcus Maurer, a highly esteemed expert who contributed significantly to touchDERMATOLOGY. Our hearts and deepest sympathies are with his family and close friends during this difficult time. His guidance, expert insights, and contributions to our platform have been invaluable. We feel privileged to have worked alongside someone whose groundbreaking work has made a significant impact on dermatology and immunology.

 

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup